EcoDrugPlus

Ensembl ID : ENSDCDG00000015403
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSDCDG00000013293
Gene Symbol: -
Cross references: -
308 Possible Orthologues:

Ensembl ID : ENSDCDG00000030789
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSDCDG00000023330
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSDCDG00000007724
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSDCDG00000020925
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSDCDG00000020838
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSDCDG00000019737
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSDCDG00000033282
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSDCDG00000000173
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSDCDG00000018831
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSDCDG00000018830
Gene Symbol: -
Cross references: -
156 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).